Literature DB >> 11819634

Current medical therapy of inflammatory bowel disease.

Kiron M Das, Sherif A Farag.   

Abstract

Entities:  

Year:  2000        PMID： 11819634      PMCID： PMC4723544          DOI： 10.3748/wjg.v6.i4.483

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN： 1007-9327            Impact factor:   5.742


× No keyword cloud information.
  67 in total

1.  Randomised controlled trial of CDP571 antibody to tumour necrosis factor-alpha in Crohn's disease.

Authors:  W A Stack; S D Mann; A J Roy; P Heath; M Sopwith; J Freeman; G Holmes; R Long; A Forbes; M A Kamm
Journal:  Lancet       Date:  1997-02-22       Impact factor: 79.321

Review 2.  Antibiotics in inflammatory bowel disease: new choices for an old disease.

Authors:  M J Spirt
Journal:  Am J Gastroenterol       Date:  1994-07       Impact factor: 10.864

3.  Low-dose intravenous azathioprine may be effective in the management of acute fulminant colitis complicating inflammatory bowel disease.

Authors:  D H Casson; S E Davies; M A Thomson; A Lewis; J A Walker-Smith; S H Murch
Journal:  Aliment Pharmacol Ther       Date:  1999-07       Impact factor: 8.171

4.  Oral 5-aminosalicylic acid (Asacol) in the maintenance treatment of Crohn's disease.

Authors:  C Prantera; F Pallone; G Brunetti; M Cottone; M Miglioli
Journal:  Gastroenterology       Date:  1992-08       Impact factor: 22.682

5.  Randomised controlled trial of azathioprine withdrawal in ulcerative colitis.

Authors:  A B Hawthorne; R F Logan; C J Hawkey; P N Foster; A T Axon; E T Swarbrick; B B Scott; J E Lennard-Jones
Journal:  BMJ       Date:  1992-07-04

6.  Rapid development of pancreatitis following reuse of 6-mercaptopurine.

Authors:  M S Cappell; K M Das
Journal:  J Clin Gastroenterol       Date:  1989-12       Impact factor: 3.062

7.  [Chronic interstitial nephritis and mesalazine: 3 new cases?].

Authors:  M Brouillard; J D Gheerbrant; Y Gheysens; D Fleury; M Devred; M Hazzan; J F Colombel
Journal:  Gastroenterol Clin Biol       Date:  1998 Aug-Sep

8.  A comparison of budesonide and mesalamine for active Crohn's disease. International Budesonide-Mesalamine Study Group.

Authors:  O O Thomsen; A Cortot; D Jewell; J P Wright; T Winter; F T Veloso; M Vatn; T Persson; E Pettersson
Journal:  N Engl J Med       Date:  1998-08-06       Impact factor: 91.245

9.  Paradoxical response to heparin in 10 patients with ulcerative colitis.

Authors:  P R Gaffney; C T Doyle; A Gaffney; J Hogan; D P Hayes; P Annis
Journal:  Am J Gastroenterol       Date:  1995-02       Impact factor: 10.864

10.  Improved growth and disease activity after intermittent administration of a defined formula diet in children with Crohn's disease.

Authors:  D B Polk; J A Hattner; J A Kerner
Journal:  JPEN J Parenter Enteral Nutr       Date:  1992 Nov-Dec       Impact factor: 4.016
View more
  11 in total

1.  Protective effects of cyclosporine A on T-cell dependent ConA-induced liver injury in Kunming mice.

Authors:  X L Zhang; Q Z Quan; Z Q Sun; Y J Wang; X L Jiang; D Wang; W B Li
Journal:  World J Gastroenterol       Date:  2001-08       Impact factor: 5.742

Review 2.  An analysis of 10218 ulcerative colitis cases in China.

Authors:  Xue-Liang Jiang; Hui-Fei Cui
Journal:  World J Gastroenterol       Date:  2002-02       Impact factor: 5.742

3.  Protective effect of Jiechangning decoction in treating experimental ulcerative colitis in guinea pigs.

Authors:  Wu-jun Xiong; Qi-yu Qiu; De-kai Qiu
Journal:  Chin J Integr Med       Date:  2005-03       Impact factor: 1.978

4.  Clinical significance of plasma D-dimer and von Willebrand factor levels in patients with ulcer colitis.

Authors:  Gang Xu; Ke-Li Tian; Guo-Ping Liu; Xue-Jun Zhong; Shao-Ling Tang; Yan-Ping Sun
Journal:  World J Gastroenterol       Date:  2002-06       Impact factor: 5.742

5.  Protective effect of angelica sinensis polysaccharide on experimental immunological colon injury in rats.

Authors:  Shao-Ping Liu; Wei-Guo Dong; Dong-Fang Wu; He-Sheng Luo; Jie-Ping Yu
Journal:  World J Gastroenterol       Date:  2003-12       Impact factor: 5.742

Review 6.  IL-10 and its related cytokines for treatment of inflammatory bowel disease.

Authors:  Ming-Cai Li; Shao-Heng He
Journal:  World J Gastroenterol       Date:  2004-03-01       Impact factor: 5.742

7.  Ameliorative effects of sodium ferulate on experimental colitis and their mechanisms in rats.

Authors:  Wei-Guo Dong; Shao-Ping Liu; Bao-Ping Yu; Dong-Fang Wu; He-Sheng Luo; Jie-Ping Yu
Journal:  World J Gastroenterol       Date:  2003-11       Impact factor: 5.742

8.  Abnormal function of platelets and role of angelica sinensis in patients with ulcerative colitis.

Authors:  Wei-Guo Dong; Shao-Ping Liu; Hai-Hang Zhu; He-Sheng Luo; Jie-Ping Yu
Journal:  World J Gastroenterol       Date:  2004-02-15       Impact factor: 5.742

9.  The Antioxidant and Anti-Inflammatory Effects of Quercus brantii Extract on TNBS-Induced Ulcerative Colitis in Rats.

Authors:  Mahvash Alizade Naini; Shayan Mehrvarzi; Asal Zargari-Samadnejadi; Nader Tanideh; Mohammad Ghorbani; Amirreza Dehghanian; Maryam Hasanzarrini; Farnaz Banaee; Omid Koohi-Hosseinabadi; Cambyz Irajie; Aida Iraji
Journal:  Evid Based Complement Alternat Med       Date:  2021-01-07       Impact factor: 2.629

10.  Investigation of H2S Donor Treatment on Neutrophil Extracellular Traps in Experimental Colitis.

Authors:  Szilvia Török; Nikoletta Almási; Zsuzsanna Valkusz; Anikó Pósa; Csaba Varga; Krisztina Kupai
Journal:  Int J Mol Sci       Date:  2021-11-25       Impact factor: 5.923
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.